The emerging role of branched-chain amino acids in insulin resistance and metabolism

Nutrients

Volumn 8, Issue 7, 2016, Pages

  Yoon, Mee Sup ^a  

^a Gachon University College of Medicine   (South Korea)

Author keywords

Branched chain amino acids (BCAAs); Insulin resistance; Mammalian target of rapamycin complex 1 (mTORC1); Metabolism

Indexed keywords

AMINO ACID TRANSPORTER; BRANCHED CHAIN AMINO ACID; BRANCHED CHAIN AMINO ACID AMINOTRANSFERASE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; INSULIN RECEPTOR; LEUCINE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; PROTEIN S6; SERINE; STRESS ACTIVATED PROTEIN KINASE; TUBERIN; VALINE; GLUCOSE BLOOD LEVEL; INSULIN; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; TARGET OF RAPAMYCIN KINASE;

AEROBIC METABOLISM; AMINO ACID METABOLISM; APOPTOSIS; AUTOPHOSPHORYLATION; DIETARY INTAKE; DNA MODIFICATION; ENZYME ACTIVATION; EPIGENETICS; GENE EXPRESSION; GENE MUTATION; GENETIC SUSCEPTIBILITY; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTESTINE FLORA; LOW FAT DIET; METABOLIC SYNDROME X; METABOLOMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHOSPHORYLATION; PROTEIN DEGRADATION; REVIEW; ANIMAL; BLOOD; DISEASE MODEL; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; RISK FACTOR;

AMINO ACIDS, BRANCHED-CHAIN; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HUMANS; INSULIN; INSULIN RESISTANCE; MULTIPROTEIN COMPLEXES; OBESITY; RISK FACTORS; TOR SERINE-THREONINE KINASES;

EID: 84977477173     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8070405     Document Type: Review

References (94)

1. Lu, J.; Xie, G.; Jia, W.; Jia, W. Insulin resistance and the metabolism of branched-chain amino acids. Front. Med. 2013, 7, 53-59. [CrossRef] [PubMed].
2. Lynch, C. J.; Adams, S. H. Branched-chain amino acids in metabolic signalling and insulin resistance. Nat. Rev. Endocrinol. 2014, 10, 723-736. [CrossRef] [PubMed].
3. Wang, T. J.; Larson, M. G.; Vasan, R. S.; Cheng, S.; Rhee, E. P.; McCabe, E.; Lewis, G. D.; Fox, C. S.; Jacques, P. F.; Fernandez, C.; et al. Metabolite profiles and the risk of developing diabetes. Nat. Med. 2011, 17, 448-453. [CrossRef] [PubMed].
4. Giesbertz, P.; Daniel, H. Branched-chain amino acids as biomarkers in diabetes. Curr. Opin. Clin. Nutr. Metab. Care 2016, 19, 48-54. [CrossRef] [PubMed].
5. Cota, D.; Proulx, K.; Smith, K. A.; Kozma, S. C.; Thomas, G.; Woods, S. C.; Seeley, R. J. Hypothalamic mTOR signaling regulates food intake. Science 2006, 312, 927-930. [CrossRef] [PubMed].
6. Blouet, C.; Jo, Y. H.; Li, X.; Schwartz, G. J. Mediobasal hypothalamic leucine sensing regulates food intake through activation of a hypothalamus-brainstem circuit. J. Neurosci. 2009, 29, 8302-8311. [CrossRef] [PubMed].
7. Torres-Leal, F. L.; Fonseca-Alaniz, M. H.; Teodoro, G. F.; de Capitani, M. D.; Vianna, D.; Pantaleão, L. C.; Matos-Neto, E. M.; Rogero, M. M.; Donato, J.; Tirapegui, J. Leucine supplementation improves adiponectin and total cholesterol concentrations despite the lack of changes in adiposity or glucose homeostasis in rats previously exposed to a high-fat diet. Nutr. Metab. 2011, 8, 62. [CrossRef] [PubMed].
8. Chen, Q.; Reimer, R. A. Dairy protein and leucine alter GLP-1 release and mRNA of genes involved in intestinal lipid metabolism in vitro. Nutrition 2009, 25, 340-349. [CrossRef] [PubMed].
9. Nilsson, M.; Holst, J. J.; Bjorck, I. M. Metabolic effects of amino acid mixtures and whey protein in healthy subjects: Studies using glucose-equivalent drinks. Am. J. Clin. Nutr. 2007, 85, 996-1004. [PubMed].
10. Sener, A.; Malaisse, W. J. The stimulus-secretion coupling of amino acid-induced insulin release: Insulinotropic action of branched-chain amino acids at physiological concentrations of glucose and glutamine. Eur. J. Clin. Invest. 1981, 11, 455-460. [CrossRef] [PubMed].
11. Vary, T. C.; Lynch, C. J. Nutrient signaling components controlling protein synthesis in striated muscle. J. Nutr. 2007, 137, 1835-1843. [PubMed].
12. Lynch, C. J.; Patson, B. J.; Anthony, J.; Vaval, A.; Jefferson, L. S.; Vary, T. C. Leucine is a direct-acting nutrient signal that regulates protein synthesis in adipose tissue. Am. J. Physiol. Endocrinol. Metab. 2002, 283, E503-E513. [CrossRef] [PubMed].
13. Dodd, K. M.; Tee, A. R. Leucine and mTORC1: A complex relationship. Am. J. Physiol. Endocrinol. Metab. 2012, 302, E1329-E1342. [CrossRef] [PubMed].
14. Giordano, M.; Castellino, P. Correlation between amino acid induced changes in energy expenditure and protein metabolism in humans. Nutrition 1997, 13, 309-312. [CrossRef].
15. Holecek, M. Three targets of branched-chain amino acid supplementation in the treatment of liver disease. Nutrition 2010, 26, 482-490. [CrossRef] [PubMed].
16. Macotela, Y.; Emanuelli, B.; Bang, A. M.; Espinoza, D. O.; Boucher, J.; Beebe, K.; Gall, W.; Kahn, C. R. Dietary leucine-An environmental modifier of insulin resistance acting on multiple levels of metabolism. PLoS ONE 2011, 6, e21187. [CrossRef] [PubMed].
17. Newgard, C. B.; An, J.; Bain, J. R.; Muehlbauer, M. J.; Stevens, R. D.; Lien, L. F.; Haqq, A. M.; Shah, S. H.; Arlotto, M.; Slentz, C. A.; et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009, 9, 311-326. [CrossRef] [PubMed].
18. Newgard, C. B. Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab. 2012, 15, 606-614. [CrossRef] [PubMed].
19. Huffman, K. M.; Shah, S. H.; Stevens, R. D.; Bain, J. R.; Muehlbauer, M.; Slentz, C. A.; Tanner, C. J.; Kuchibhatla, M.; Houmard, J. A.; Newgard, C. B.; et al. Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care 2009, 32, 1678-1683. [CrossRef] [PubMed].
20. Chen, T.; Ni, Y.; Ma, X.; Bao, Y.; Liu, J.; Huang, F.; Hu, C.; Xie, G.; Zhao, A.; Jia, W.; et al. Branched-chain and aromatic amino acid profiles and diabetes risk in Chinese populations. Sci. Rep. 2016, 6, 20594. [CrossRef] [PubMed].
21. Knebel, B.; Strassburger, K.; Szendroedi, J.; Kotzka, J.; Scheer, M.; Nowotny, B.; Mussig, K.; Lehr, S.; Pacini, G.; Finner, H.; et al. Specific metabolic profiles and their relationship to insulin resistance in recent-onset type-1 and type-2 diabetes. J. Clin. Endocrinol. Metab. 2016, 101, 2130-2140. [CrossRef] [PubMed].
22. Shaham, O.; Wei, R.; Wang, T. J.; Ricciardi, C.; Lewis, G. D.; Vasan, R. S.; Carr, S. A.; Thadhani, R.; Gerszten, R. E.; Mootha, V. K. Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol. Syst. Biol. 2008, 4, 214. [CrossRef] [PubMed].
23. Hattersley, J. G.; Pfeiffer, A. F.; Roden, M.; Petzke, K. J.; Hoffmann, D.; Rudovich, N. N.; Randeva, H. S.; Vatish, M.; Osterhoff, M.; Goegebakan, O.; et al. Modulation of amino acid metabolic signatures by supplemented isoenergetic diets differing in protein and cereal fiber content. J. Clin. Endocrinol. Metab. 2014, 99, E2599-E2609. [CrossRef] [PubMed].
24. Fiehn, O.; Garvey, W. T.; Newman, J. W.; Lok, K. H.; Hoppel, C. L.; Adams, S. H. Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS ONE 2010, 5, e15234. [CrossRef] [PubMed].
25. McCormack, S. E.; Shaham, O.; McCarthy, M. A.; Deik, A. A.; Wang, T. J.; Gerszten, R. E.; Clish, C. B.; Mootha, V. K.; Grinspoon, S. K.; Fleischman, A. Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents. Pediatr. Obes. 2013, 8, 52-61. [CrossRef] [PubMed].
26. Fernstrom, J. D. Branched-chain amino acids and brain function. J. Nutr. 2005, 135, 1539S-1546S. [PubMed].
27. Sarbassov, D. D.; Ali, S. M.; Sabatini, D. M. Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 2005, 17, 596-603. [CrossRef] [PubMed].
28. Zoncu, R.; Efeyan, A.; Sabatini, D. M. mTOR: From growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 2011, 12, 21-35. [CrossRef] [PubMed].
29. Bar-Peled, L.; Sabatini, D. M. Regulation of mTORC1 by amino acids. Trends Cell Biol. 2014, 24, 400-406. [CrossRef] [PubMed].
30. Jewell, J. L.; Russell, R. C.; Guan, K. L. Amino acid signalling upstream of mTOR. Nat. Rev. Mol. Cell Biol. 2013, 14, 133-139. [CrossRef] [PubMed].
31. Sancak, Y.; Peterson, T. R.; Shaul, Y. D.; Lindquist, R. A.; Thoreen, C. C.; Bar-Peled, L.; Sabatini, D. M. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 2008, 320, 1496-1501. [CrossRef] [PubMed].
32. Zoncu, R.; Bar-Peled, L.; Efeyan, A.; Wang, S.; Sancak, Y.; Sabatini, D. M. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science 2011, 334, 678-683. [CrossRef] [PubMed].
33. Sancak, Y.; Bar-Peled, L.; Zoncu, R.; Markhard, A. L.; Nada, S.; Sabatini, D. M. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010, 141, 290-303. [CrossRef] [PubMed].
34. Bar-Peled, L.; Schweitzer, L. D.; Zoncu, R.; Sabatini, D. M. Ragulator is a GEF for the Rag GTPases that signal amino acid levels to mTORC1. Cell 2012, 150, 1196-1208. [CrossRef] [PubMed].
35. Tsun, Z. Y.; Bar-Peled, L.; Chantranupong, L.; Zoncu, R.; Wang, T.; Kim, C.; Spooner, E.; Sabatini, D. M. The folliculin tumor suppressor is a GAP for the RagC/D GTPases that signal amino acid levels to mTORC1. Mol. Cell 2013, 52, 495-505. [CrossRef] [PubMed].
36. Han, J. M.; Jeong, S. J.; Park, M. C.; Kim, G.; Kwon, N. H.; Kim, H. K.; Ha, S. H.; Ryu, S. H.; Kim, S. Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. Cell 2012, 149, 410-424. [CrossRef] [PubMed].
37. Bar-Peled, L.; Chantranupong, L.; Cherniack, A. D.; Chen, W. W.; Ottina, K. A.; Grabiner, B. C.; Spear, E. D.; Carter, S. L.; Meyerson, M.; Sabatini, D. M. A tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science 2013, 340, 1100-1106. [CrossRef] [PubMed].
38. Chantranupong, L.; Wolfson, R. L.; Orozco, J. M.; Saxton, R. A.; Scaria, S. M.; Bar-Peled, L.; Spooner, E.; Isasa, M.; Gygi, S. P.; Sabatini, D. M. The Sestrins interact with GATOR2 to negatively regulate the amino-acid-sensing pathway upstream of mTORC1. Cell Rep. 2014, 9, 1-8. [CrossRef] [PubMed].
39. Wolfson, R. L.; Chantranupong, L.; Saxton, R. A.; Shen, K.; Scaria, S. M.; Cantor, J. R.; Sabatini, D. M. Sestrin2 is a leucine sensor for the mTORC1 pathway. Science 2016, 351, 43-48. [CrossRef] [PubMed].
40. Yoon, M. S.; Du, G.; Backer, J. M.; Frohman, M. A.; Chen, J. Class III Pi-3-kinase activates phospholipase D in an amino acid-sensing mTORC1 pathway. J. Cell Biol. 2011, 195, 435-447. [CrossRef] [PubMed].
41. Fang, Y.; Vilella-Bach, M.; Bachmann, R.; Flanigan, A.; Chen, J. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 2001, 294, 1942-1945. [CrossRef] [PubMed].
42. Yoon, M. S.; Rosenberger, C. L.; Wu, C.; Truong, N.; Sweedler, J. V.; Chen, J. Rapid mitogenic regulation of the mTORC1 inhibitor, deptor, by phosphatidic acid. Mol. Cell 2015, 58, 549-556. [CrossRef] [PubMed].
43. Ma, X. M.; Blenis, J. Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 2009, 10, 307-318. [CrossRef] [PubMed].
44. Yu, Y.; Yoon, S. O.; Poulogiannis, G.; Yang, Q.; Ma, X. M.; Villen, J.; Kubica, N.; Hoffman, G. R.; Cantley, L. C.; Gygi, S. P.; et al. Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 2011, 332, 1322-1326. [CrossRef] [PubMed].
45. Manning, B. D. Balancing Akt with S6K: Implications for both metabolic diseases and tumorigenesis. J. Cell Biol. 2004, 167, 399-403. [CrossRef] [PubMed].
46. White, M. F. The IRS-signalling system: A network of docking proteins that mediate insulin action. Mol. Cell. Biochem. 1998, 182, 3-11. [CrossRef] [PubMed].
47. Alessi, D. R.; Kozlowski, M. T.; Weng, Q. P.; Morrice, N.; Avruch, J. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr. Biol. 1998, 8, 69-81. [CrossRef].
48. Harrington, L. S.; Findlay, G. M.; Gray, A.; Tolkacheva, T.; Wigfield, S.; Rebholz, H.; Barnett, J.; Leslie, N. R.; Cheng, S.; Shepherd, P. R.; et al. The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J. Cell Biol. 2004, 166, 213-223. [CrossRef] [PubMed].
49. Ozes, O. N.; Akca, H.; Mayo, L. D.; Gustin, J. A.; Maehama, T.; Dixon, J. E.; Donner, D. B. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc. Natl. Acad. Sci. USA 2001, 98, 4640-4645. [CrossRef] [PubMed].
50. Tremblay, F.; Brule, S.; Hee Um, S.; Li, Y.; Masuda, K.; Roden, M.; Sun, X. J.; Krebs, M.; Polakiewicz, R. D.; Thomas, G.; et al. Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient-and obesity-induced insulin resistance. Proc. Natl. Acad. Sci. USA 2007, 104, 14056-14061. [CrossRef] [PubMed].
51. Carlson, C. J.; White, M. F.; Rondinone, C. M. Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation. Biochem. Biophys. Res. Commun. 2004, 316, 533-539. [CrossRef] [PubMed].
52. Tremblay, F.; Krebs, M.; Dombrowski, L.; Brehm, A.; Bernroider, E.; Roth, E.; Nowotny, P.; Waldhausl, W.; Marette, A.; Roden, M. Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes 2005, 54, 2674-2684. [CrossRef] [PubMed].
53. She, P.; Reid, T. M.; Bronson, S. K.; Vary, T. C.; Hajnal, A.; Lynch, C. J.; Hutson, S. M. Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab. 2007, 6, 181-194. [CrossRef] [PubMed].
54. Weickert, M. O.; Roden, M.; Isken, F.; Hoffmann, D.; Nowotny, P.; Osterhoff, M.; Blaut, M.; Alpert, C.; Gogebakan, O.; Bumke-Vogt, C.; et al. Effects of supplemented isoenergetic diets differing in cereal fiber and protein content on insulin sensitivity in overweight humans. Am. J. Clin. Nutr. 2011, 94, 459-471. [CrossRef] [PubMed].
55. Magkos, F.; Bradley, D.; Schweitzer, G. G.; Finck, B. N.; Eagon, J. C.; Ilkayeva, O.; Newgard, C. B.; Klein, S. Effect of Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding on branched-chain amino acid metabolism. Diabetes 2013, 62, 2757-2761. [CrossRef] [PubMed].
56. Adams, S. H. Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Adv. Nutr. 2011, 2, 445-456. [CrossRef] [PubMed].
57. D'Antona, G.; Ragni, M.; Cardile, A.; Tedesco, L.; Dossena, M.; Bruttini, F.; Caliaro, F.; Corsetti, G.; Bottinelli, R.; Carruba, M. O.; et al. Branched-chain amino acid supplementation promotes survival and supports cardiac and skeletal muscle mitochondrial biogenesis in middle-aged mice. Cell Metab. 2010, 12, 362-372. [CrossRef] [PubMed].
58. Mordier, S.; Deval, C.; Bechet, D.; Tassa, A.; Ferrara, M. Leucine limitation induces autophagy and activation of lysosome-dependent proteolysis in C2C12 myotubes through a mammalian target of rapamycin-independent signaling pathway. J. Biol. Chem. 2000, 275, 29900-29906. [CrossRef] [PubMed].
59. Sugawara, T.; Ito, Y.; Nishizawa, N.; Nagasawa, T. Regulation of muscle protein degradation, not synthesis, by dietary leucine in rats fed a protein-deficient diet. Amino Acids 2009, 37, 609-616. [CrossRef] [PubMed].
60. Baptista, I. L.; Leal, M. L.; Artioli, G. G.; Aoki, M. S.; Fiamoncini, J.; Turri, A. O.; Curi, R.; Miyabara, E. H.; Moriscot, A. S. Leucine attenuates skeletal muscle wasting via inhibition of ubiquitin ligases. Muscle Nerve 2010, 41, 800-808. [CrossRef] [PubMed].
61. Felig, P.; Marliss, E.; Cahill, G. F., Jr. Plasma amino acid levels and insulin secretion in obesity. N. Engl. J. Med. 1969, 281, 811-816. [CrossRef] [PubMed].
62. Felig, P.; Marliss, E.; Cahill, G. F., Jr. Are plasma amino acid levels elevated in obesity? N. Engl. J. Med. 1970, 282, 166. [PubMed].
63. Tai, E. S.; Tan, M. L.; Stevens, R. D.; Low, Y. L.; Muehlbauer, M. J.; Goh, D. L.; Ilkayeva, O. R.; Wenner, B. R.; Bain, J. R.; Lee, J. J.; et al. Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia 2010, 53, 757-767. [CrossRef] [PubMed].
64. O'Connor, P. M.; Bush, J. A.; Suryawan, A.; Nguyen, H. V.; Davis, T. A. Insulin and amino acids independently stimulate skeletal muscle protein synthesis in neonatal pigs. Am. J. Physiol. Endocrinol. Metab. 2003, 284, E110-E119. [CrossRef] [PubMed].
65. Fryburg, D. A.; Jahn, L. A.; Hill, S. A.; Oliveras, D. M.; Barrett, E. J. Insulin and insulin-like growth factor-i enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms. J. Clin. Invest. 1995, 96, 1722-1729. [CrossRef] [PubMed].
66. Greenhaff, P. L.; Karagounis, L. G.; Peirce, N.; Simpson, E. J.; Hazell, M.; Layfield, R.; Wackerhage, H.; Smith, K.; Atherton, P.; Selby, A.; et al. Disassociation between the effects of amino acids and insulin on signaling, ubiquitin ligases, and protein turnover in human muscle. Am. J. Physiol. Endocrinol. Metab. 2008, 295, E595-E604. [CrossRef] [PubMed].
67. Estornell, E.; Cabo, J.; Barber, T. Protein synthesis is stimulated in nutritionally obese rats. J. Nutr. 1995, 125, 1309-1315. [PubMed].
68. Guillet, C.; Masgrau, A.; Boirie, Y. Is protein metabolism changed with obesity? Curr. Opin. Clin. Nutr. Metab. Care 2011, 14, 89-92. [CrossRef] [PubMed].
69. Welle, S.; Barnard, R. R.; Statt, M.; Amatruda, J. M. Increased protein turnover in obese women. Metabolism 1992, 41, 1028-1034. [CrossRef].
70. Neis, E. P.; Dejong, C. H.; Rensen, S. S. The role of microbial amino acid metabolism in host metabolism. Nutrients 2015, 7, 2930-2946. [CrossRef] [PubMed].
71. Metges, C. C. Contribution of microbial amino acids to amino acid homeostasis of the host. J. Nutr. 2000, 130, 1857S-1864S. [PubMed].
72. Krajmalnik-Brown, R.; Ilhan, Z. E.; Kang, D. W.; DiBaise, J. K. Effects of gut microbes on nutrient absorption and energy regulation. Nutr. Clin. Pract. 2012, 27, 201-214. [CrossRef] [PubMed].
73. Lu, G.; Sun, H.; She, P.; Youn, J. Y.; Warburton, S.; Ping, P.; Vondriska, T. M.; Cai, H.; Lynch, C. J.; Wang, Y. Protein phosphatase 2 cm is a critical regulator of branched-chain amino acid catabolism in mice and cultured cells. J. Clin. Invest. 2009, 119, 1678-1687. [CrossRef] [PubMed].
74. Zimmerman, H. A.; Olson, K. C.; Chen, G.; Lynch, C. J. Adipose transplant for inborn errors of branched chain amino acid metabolism in mice. Mol. Genet. Metab. 2013, 109, 345-353. [CrossRef] [PubMed].
75. Oyarzabal, A.; Martinez-Pardo, M.; Merinero, B.; Navarrete, R.; Desviat, L. R.; Ugarte, M.; Rodriguez-Pombo, P. A novel regulatory defect in the branched-chain alpha-keto acid dehydrogenase complex due to a mutation in the PPM1K gene causes a mild variant phenotype of maple syrup urine disease. Hum. Mutat. 2013, 34, 355-362. [CrossRef] [PubMed].
76. Jackson, R. H.; Singer, T. P. Inactivation of the 2-ketoglutarate and pyruvate dehydrogenase complexes of beef heart by branched chain keto acids. J. Biol. Chem. 1983, 258, 1857-1865. [PubMed].
77. Walajtys-Rode, E.; Williamson, J. R. Effects of branched chain alpha-ketoacids on the metabolism of isolated rat liver cells. III. Interactions with pyruvate dehydrogenase. J. Biol. Chem. 1980, 255, 413-418. [PubMed].
78. Lackey, D. E.; Lynch, C. J.; Olson, K. C.; Mostaedi, R.; Ali, M.; Smith, W. H.; Karpe, F.; Humphreys, S.; Bedinger, D. H.; Dunn, T. N.; et al. Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity. Am. J. Physiol. Endocrinol. Metab. 2013, 304, E1175-E1187. [CrossRef] [PubMed].
79. Herman, M. A.; She, P.; Peroni, O. D.; Lynch, C. J.; Kahn, B. B. Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels. J. Biol. Chem. 2010, 285, 11348-11356. [CrossRef] [PubMed].
80. Lefort, N.; Glancy, B.; Bowen, B.; Willis, W. T.; Bailowitz, Z.; De Filippis, E. A.; Brophy, C.; Meyer, C.; Hojlund, K.; Yi, Z.; et al. Increased reactive oxygen species production and lower abundance of complex i subunits and carnitine palmitoyltransferase 1B protein despite normal mitochondrial respiration in insulin-resistant human skeletal muscle. Diabetes 2010, 59, 2444-2452. [CrossRef] [PubMed].
81. Shin, A. C.; Fasshauer, M.; Filatova, N.; Grundell, L. A.; Zielinski, E.; Zhou, J. Y.; Scherer, T.; Lindtner, C.; White, P. J.; Lapworth, A. L.; et al. Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism. Cell Metab. 2014, 20, 898-909. [CrossRef] [PubMed].
82. Mullen, E.; Ohlendieck, K. Proteomic profiling of non-obese type 2 diabetic skeletal muscle. Int. J. Mol. Med. 2010, 25, 445-458. [PubMed].
83. Kadota, Y.; Toyoda, T.; Kitaura, Y.; Adams, S. H.; Shimomura, Y. Regulation of hepatic branched-chain alpha-ketoacid dehydrogenase complex in rats fed a high-fat diet. Obes. Res. Clin. Pract. 2013, 2013, 7, e439-e444. [CrossRef].
84. Tiffin, N.; Adie, E.; Turner, F.; Brunner, H. G.; van Driel, M. A.; Oti, M.; Lopez-Bigas, N.; Ouzounis, C.; Perez-Iratxeta, C.; Andrade-Navarro, M. A.; et al. Computational disease gene identification: A concert of methods prioritizes type 2 diabetes and obesity candidate genes. Nucleic Acids Res. 2006, 34, 3067-3081. [CrossRef] [PubMed].
85. Taneera, J.; Lang, S.; Sharma, A.; Fadista, J.; Zhou, Y.; Ahlqvist, E.; Jonsson, A.; Lyssenko, V.; Vikman, P.; Hansson, O.; et al. A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metab. 2012, 16, 122-134. [CrossRef] [PubMed].
86. Xu, M.; Nagasaki, M.; Obayashi, M.; Sato, Y.; Tamura, T.; Shimomura, Y. Mechanism of activation of branched-chain alpha-keto acid dehydrogenase complex by exercise. Biochem. Biophys. Res. Commun. 2011, 287, 752-756. [CrossRef] [PubMed].
87. Paxton, R.; Harris, R. A. Regulation of branched-chain alpha-ketoacid dehydrogenase kinase. Arch. Biochem. Biophys. 1984, 231, 48-57. [CrossRef].
88. Corkey, B. E.; Martin-Requero, A.; Walajtys-Rode, E.; Williams, R. J.; Williamson, J. R. Regulation of the branched chain alpha-ketoacid pathway in liver. J. Biol. Chem. 1982, 257, 9668-9676. [PubMed].
89. Hu, H.; Jaskiewicz, J. A.; Harris, R. A. Ethanol and oleate inhibition of alpha-ketoisovalerate and 3-hydroxyisobutyrate metabolism by isolated hepatocytes. Arch. Biochem. Biophys. 1992, 299, 57-62. [CrossRef].
90. Frohnert, B. I.; Sinaiko, A. R.; Serrot, F. J.; Foncea, R. E.; Moran, A.; Ikramuddin, S.; Choudry, U.; Bernlohr, D. A. Increased adipose protein carbonylation in human obesity. Obesity 2011, 19, 1735-1741. [CrossRef] [PubMed].
91. Ruskovska, T.; Bernlohr, D. A. Oxidative stress and protein carbonylation in adipose tissue-Implications for insulin resistance and diabetes mellitus. J. Proteom. 2013, 92, 323-334. [CrossRef] [PubMed].
92. Piccolo, B. D.; Comerford, K. B.; Karakas, S. E.; Knotts, T. A.; Fiehn, O.; Adams, S. H. Whey protein supplementation does not alter plasma branched-chained amino acid profiles but results in unique metabolomics patterns in obese women enrolled in an 8-week weight loss trial. J. Nutr. 2015, 145, 691-700. [CrossRef] [PubMed].
93. Piccolo, B. D.; Graham, J. L.; Stanhope, K. L.; Fiehn, O.; Havel, P. J.; Adams, S. H. Plasma amino acid and metabolite signatures tracking diabetes progression in the UCD-T2DM rat model of type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 2016. [CrossRef] [PubMed].
94. Adams, S. H.; Hoppel, C. L.; Lok, K. H.; Zhao, L.; Wong, S. W.; Minkler, P. E.; Hwang, D. H.; Newman, J. W.; Garvey, W. T. Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. J. Nutr. 2009, 139, 1073-1081. [CrossRef] [PubMed].